A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is an open-label study that will compare the pharmacokinetic and safety effects of
naproxcinod in hepatic impaired patients vs. matching healthy subjects.